| Somogyi | Michael, U.S. Biochemist, 1883-1971. See: Somogyi effect, Somogyi method, Somogyi unit. (05 Mar 2000) |
|---|---|
| Somogyi effect | In diabetes, a rebound phenomenon of reactive hyperglycaemia in response to a preceding period of relative hypoglycaemia that has increased secretion of hyperglycaemic agents (epinephrine, norepinephrine, glucagon, cortisol, and growth hormone); described in diabetic patients given too much insulin who developed unrecognised nocturnal hypoglycaemia that made them hyperglycaemic (suggesting insufficient insulin) when tested the next morning. (05 Mar 2000) |
| Somogyi method | A measure of the level of activity of amylase in blood serum, as analyzed by means of the Somogyi method (the most frequently used procedure); one unit is equivalent to 1 mg of reducing sugar liberated as glucose per 100 ml of serum, when an aliquot of the latter is mixed with a standard starch substrate (plus sodium chloride for maximal activation) and incubated for a standard time; normal range is 80 to 150 unit's, but values are usually not regarded as clinically significant unless they are greater than 200. (05 Mar 2000) |
| Somogyi phenomenon | A rebound phenomenon of reactive hyperglycaemia following a period of relative hypoglycaemia, which may be subclinical and difficult to detect; the hyperglycaemia induces use of more insulin, thus aggravating the problem. Synonym: posthypoglycaemic hyperglycaemia. (05 Mar 2000) |
| Somogyi unit | A measure of the level of activity of amylase in blood serum, as analyzed by means of the Somogyi method (the most frequently used procedure); one unit is equivalent to 1 mg of reducing sugar liberated as glucose per 100 ml of serum, when an aliquot of the latter is mixed with a standard starch substrate (plus sodium chloride for maximal activation) and incubated for a standard time; normal range is 80 to 150 unit's, but values are usually not regarded as clinically significant unless they are greater than 200. (05 Mar 2000) |
| Somogyi effect |
a rebound effect of low followed by high blood glucose caused by too much insulin
출처: www.diabetes.org.au/glossary.htm
|
|---|---|
| Somogyi phenomenon |
A special type of nighttime rebound phenomenon with high blood glucose level in the morning.
출처: www.bddiabetes.co.uk/dyn_en/glossary.html
|
| Somogyi e. |
see under phenomenon.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| Somogyi m. |
(for amylase activity) a method based on the disappearance of the blue color given by iodine and amylose (linear fraction of starch) after amylase in serum, urine, etc., is allowed to act on starch.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| Somogyi p. |
a rebound phenomenon occurring in diabetes mellitus: overtreatment with insulin induces hypoglycemia, which initiates the release of epinephrine, corticotropin, glucagon, and growth hormone, which stimulate lipolysis, gluconeogenesis, and glycogenolysis, which in turn result in hyperglycemia. Called also rebound hyperglycemia and Somogyi effect.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|